DOI:
10.1055/s-00000003
Aktuelle Ernährungsmedizin
LinksClose Window
References
Crawford J, Prado CMM, Johnston MA. et al.
Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials).
Curr Oncol Rep 2016;
18: 37
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.